Unknown

Dataset Information

Kv1.3 blockade by ShK186 modulates CD4+ effector memory T-cell activity of patients with granulomatosis with polyangiitis.


ABSTRACT:

Objectives

Granulomatosis with polyangiitis (GPA) is a chronic relapsing systemic autoimmune vasculitis. Current treatment of GPA is unsatisfactory, as it relies on strong immunosuppressive regimens, with either CYC or rituximab, which reduce the immunogenicity of several vaccines and are risk factors for a severe form of COVID-19. This emphasizes the need to identify new drug targets and to develop treatment strategies with less harmful side effects. Since CD4+ effector memory T cells (TEM) play a key role in the pathogenesis of GPA, we aimed in this study to modulate CD4+TEM cell activity via Kv1.3 blockade using the specific peptide inhibiter, ShK-186.

Methods

Peripheral blood samples from 27 patients with GPA in remission and 16 age- and sex-matched healthy controls (HCs

SUBMITTER: Lintermans LL 

PROVIDER: S-EPMC10765141 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature